FibroGen, Inc. (FGEN)
NASDAQ: FGEN · Real-Time Price · USD
0.706
-0.067 (-8.61%)
At close: Feb 21, 2025, 4:00 PM
0.658
-0.048 (-6.80%)
After-hours: Feb 21, 2025, 7:59 PM EST
FibroGen Stock Forecast
FGEN's stock price has decreased by -60.78% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 1 analyst with a 12-month price forecast for FibroGen stock has a target of 10, which predicts an increase of 1,316.63% from the current stock price of 0.71.
Analyst Consensus: Strong Buy
Analyst Ratings
According to 1 stock analyst, the rating for FibroGen is "Strong Buy". This means that the analyst believes this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
Rating | Sep '24 | Oct '24 | Nov '24 | Dec '24 | Jan '25 | Feb '25 |
---|---|---|---|---|---|---|
Strong Buy | 0 | 0 | 0 | 0 | 0 | 1 |
Buy | 0 | 0 | 0 | 0 | 0 | 0 |
Hold | 4 | 4 | 4 | 4 | 4 | 0 |
Sell | 1 | 1 | 1 | 1 | 1 | 0 |
Strong Sell | 1 | 1 | 1 | 1 | 1 | 0 |
Total | 6 | 6 | 6 | 6 | 6 | 1 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $10 | Strong Buy | Reiterates | $10 | +1,316.63% | Feb 20, 2025 |
B of A Securities | B of A Securities | Hold → Sell Downgrades $4 → $2 | Hold → Sell | Downgrades | $4 → $2 | +183.33% | Aug 8, 2023 |
Goldman Sachs | Goldman Sachs | Strong Sell Maintains $16 → $2 | Strong Sell | Maintains | $16 → $2 | +183.33% | Jun 27, 2023 |
Raymond James | Raymond James | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | Jun 27, 2023 |
B of A Securities | B of A Securities | Strong Buy → Hold Downgrades $29 → $4 | Strong Buy → Hold | Downgrades | $29 → $4 | +466.65% | Jun 26, 2023 |
Financial Forecast
Revenue This Year
180.13M
from 147.75M
Increased by 21.91%
Revenue Next Year
168.31M
from 180.13M
Decreased by -6.56%
EPS This Year
-0.82
from -2.92
EPS Next Year
-0.46
from -0.82
Revenue Forecast
Revenue | 2024 | 2025 | 2026 | 2028 |
---|---|---|---|---|
High | 185.8M | 194.3M | 213.7M | |
Avg | 180.1M | 168.3M | 180.8M | |
Low | 172.7M | 142.1M | 148.0M |
Revenue Growth
Revenue Growth | 2024 | 2025 | 2026 | 2028 |
---|---|---|---|---|
High | 25.8% | 7.8% | 27.0% | |
Avg | 21.9% | -6.6% | 7.4% | |
Low | 16.9% | -21.1% | -12.1% |
EPS Forecast
EPS | 2024 | 2025 | 2026 |
---|---|---|---|
High | -0.78 | -0.40 | -0.21 |
Avg | -0.82 | -0.46 | -0.39 |
Low | -0.84 | -0.52 | -0.55 |
EPS Growth
EPS Growth | 2024 | 2025 | 2026 |
---|---|---|---|
High | - | - | - |
Avg | - | - | - |
Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.